27.67 USD
↗ 0.25 (0.91%)AT CLOSE (11:59 AM EDT)
NewAmsterdam Pharma Company N.V. Ordinary Shares
NAMSNASDAQ • USD
28.79
↗ 1.12 (4.04%)
POST MARKET (AS OF 07:37 PM EDT)
Post Market
AS OF 07:37 PM EDT
28.79
↗ 1.12 (4.04%)
Market: CLOSED
Shares of NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) are trading at $27.62. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, NAMS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 6, 2026.
Open?$27.63
High?$27.98
Low?$27.30
Prev. Close?$27.42
Volume?1.6M
Avg. Volume?1.1M
VWAP?$27.61
Rel. Volume?1.55x
Bid / Ask
Bid?$27.50 × 100
Ask?$28.79 × 100
Spread?$1.29
Midpoint?$28.15
Valuation & Ratios
Market Cap?3.2B
Shares Out?116.9M
Float?62.2M
Float %?53.2%
P/E Ratio?N/A
P/B Ratio?5.12
EPS?-$2.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
Employees
100
Market Cap
3.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-11-23
Address
GOOIMEER 2-35
NARRDEN, P7 1411 DC
Phone: 35 206 2971
NARRDEN, P7 1411 DC
Phone: 35 206 2971
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?14
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?24.70Safe
Confidence?55%Low
Short InterestVery High
Short % of Float?14.75%High
Short Interest?9.2M
Days to Cover?11.2
Free Float62.2M
Avg Daily Volume819.1K
Settlement Date2026-07-15
Financial Health
Current Ratio?9.03Strong
Quick Ratio?9.03Strong
Cash Ratio?5.81Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.12FAIR▾
Peers100
S&P36
P/S?454.25HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-11.5CHEAP▾
S&P97
EV/Sales?394.69HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-41.1%WEAK▾
S&P3
ROA?-36.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-143722000
Enterprise Value?$2.8B
Fundamentals ratios updated end of day